Literature DB >> 6987579

Paraneoplastic hypercalcemia in gynecologic malignancy.

G Holtz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6987579     DOI: 10.1097/00006254-198003000-00001

Source DB:  PubMed          Journal:  Obstet Gynecol Surv        ISSN: 0029-7828            Impact factor:   2.347


× No keyword cloud information.
  6 in total

1.  Persistent and moderate hypercalcemia related to an ovarian clear cell adenocarcinoma: Pre- and postoperative parathyroid hormone related-peptide and 1,25-dihydroxyvitamin D3 levels.

Authors:  A Benit; J Allard; J Rimailho; J Fauvel; G Escourrou; D Vezzosi; F Donadille; A Bennet; P Caron
Journal:  J Endocrinol Invest       Date:  2006-05       Impact factor: 4.256

2.  Hypertrophic osteopathy secondary to metastatic ovarian adenocarcinoma in a mare.

Authors:  Nimet S Browne; William K Scarratt; John Robertson
Journal:  Can Vet J       Date:  2016-12       Impact factor: 1.008

Review 3.  Response of paraneoplastic syndromes to antineoplastic therapy.

Authors:  M Markman
Journal:  West J Med       Date:  1986-05

4.  Ovarian carcinoma producing parathyroid hormone-related protein causing hypercalcemia and metastatic calcification detected on (18)F-FDG PET-CT.

Authors:  Krishan Kant Agarwal; Sellam Karunanithi; Sachin Jain; Rakesh Kumar
Journal:  Indian J Nucl Med       Date:  2013-10

5.  A Case of Ovarian Clear Cell Carcinoma Simultaneously Producing Parathyroid Hormone-related Protein and Granulocyte Colony-Stimulating Factor.

Authors:  Masayuki Futagami; Yoshihito Yokoyama; Moe Wakui; Ryousuke Taniguchi; Tsuyoshi Higuchi; Hideki Mizunuma
Journal:  World J Oncol       Date:  2010-05-19

6.  Hypercalcemia associated with a malignant brenner tumor arising from a mature cystic teratoma.

Authors:  Michael C Honigberg; Leslie S Bradford; Anand M Prabhakar; Lida P Hariri; Annekathryn Goodman
Journal:  Case Rep Oncol       Date:  2012-11-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.